Stefan Engst
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
Papers in
-
- Biochemical and Molecular Research 4
- Microbial Metabolic Engineering and Bioproduction 3
- PI3K/AKT/mTOR signaling in cancer 3
- Peroxisome Proliferator-Activated Receptors 2
-
- Metabolism and Genetic Disorders 6
- Co-authors
- Peiwen Yu (3 shared papers)Alison Joly (3 shared papers)F. Michael Yakes (3 shared papers)Frauke Bentzien (3 shared papers)Jenny Tan (2 shared papers)Toshihiro Yamaguchi (2 shared papers)Fawn Qian (2 shared papers)Yongchang Shi (2 shared papers)
- Journals
- Biochemistry (6 papers)Cancer Research (2 papers)Journal of Inherited Metabolic Disease (1 paper)Human Genetics (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Stefan Engst
16 papers receiving 2.0k citations
Stefan Engst's Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 347
- Clinical Biochemistry 169
- Oncology 554
- Pathology and Forensic Medicine 261
- Pulmonary and Respiratory Medicine 466
Countries citing papers authored by Stefan Engst
This map shows the geographic impact of Stefan Engst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Engst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Engst more than expected).
Fields of papers citing papers by Stefan Engst
This network shows the impact of papers produced by Stefan Engst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Engst. The network helps show where Stefan Engst may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Engst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth Hit paper breakdown → | 2011 | 1054 |
| 2 | 2009 | 284 | |
| 3 | 2011 | 200 | |
| 4 | 2013 | 106 | |
| 5 | 2017 | 99 | |
| 6 | 1990 | 73 | |
| 7 | 1991 | 63 | |
| 8 | 1998 | 42 | |
| 9 | 1999 | 40 | |
| 10 | 1998 | 28 | |
| 11 | 1997 | 27 | |
| 12 | 1998 | 16 | |
| 13 | 1999 | 9 | |
| 14 | 1991 | 8 | |
| 15 | Alpha, beta-dehydrogenation by acyl-CoA dehydrogenases: role of functional groups at the active center. | 1992 | 3 |
| 16 | 1999 | 2 |
About Stefan Engst
Stefan Engst is a scholar working on Molecular Biology, Clinical Biochemistry, Materials Chemistry, Pathology and Forensic Medicine and Spectroscopy, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), Biochemical and Molecular Research (4 papers), Advanced Nanomaterials in Catalysis (3 papers), Microbial Metabolic Engineering and Bioproduction (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Hepatology (347 citations), Clinical Biochemistry (169 citations), Oncology (554 citations), Pathology and Forensic Medicine (261 citations) and Pulmonary and Respiratory Medicine (466 citations). Stefan Engst has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Peiwen Yu, Alison Joly, F. Michael Yakes, Frauke Bentzien, Jenny Tan, Toshihiro Yamaguchi, Fawn Qian, Yongchang Shi, Felix Chu and Belinda Cancilla. Their work appears in journals such as Biochemistry, Cancer Research, Journal of Inherited Metabolic Disease, Human Genetics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.